Red de Enfermedades Vasculares Cerebrales

INVICTUS Red de Enfermedades Vasculares Cerebrales

La Red se ordena y estructura para funcionar como un instrumento de coordinación estable entre los diversos centros que la componen. Desde este punto de vista el objetivo de la Red es la coordinación de la actividad investigadora que realizan los distintos grupos rompiendo con el aislamiento en el que hasta ahora se desarrollaban sus actividades.

La Red de Investigación Cooperativa de Enfermedades Vasculares Cerebrales (INVICTUS) está integrada por 11 grupos de diferentes comunidades, incluye centros de hospitales, universidades e institutos de investigación.

Noticias
toda la actualidad

19/10/2021 Noticias INVICTUS

V CONGRESO ANUAL INVICTUS +

V CONGRESO ANUAL INVICTUS + Santiago de Compostela, 18 y 19 de noviembre de 2021 (...)

08/11/2019 Noticias INVICTUS

Congreso Anual de la Red INVICTUS+

III CONGRESO ANUAL INVICTUS + Santiago de Compostela, 7 y 8 de noviembre de 2019 (...)

Publicaciones
en revistas científicas

Intra- and extra-hospital improvement in ischemic stroke patients: influence of reperfusion therapy and molecular mechanisms.

28/02/2020

[Constraint-induced movement therapy in the rehabilitation of hemineglect after a stroke].

27/02/2020

Shape effect in active targeting of nanoparticles to inflamed cerebral endothelium under static and flow conditions.

27/02/2020

Age- and Sex-Specific Risk Profiles and In-Hospital Mortality in 13,932 Spanish Stroke Patients.

27/02/2020

Elevated circulating metalloproteinase 7 predicts recurrent cardiovascular events in patients with carotid stenosis: a prospective cohort study.

27/02/2020

Signal transducer and activator of transcription 3 (STAT3) phosphorylation regulates thromboxane A2 receptor activity in human platelets.

27/02/2020

Lesions causing hallucinations localize to one common brain network.

27/02/2020

Mediterranean Diet and Physical Activity Protect from Silent Brain Infarcts in a Cohort of Patients with Atrial Fibrillation.

27/02/2020

Early microvascular cerebral blood flow response to head-of-bed elevation is related to outcome in acute ischemic stroke.

27/02/2020

Oral anticoagulation and left atrial appendage closure: a new strategy for recurrent cardioembolic stroke.

27/02/2020

Low dose of extracellular vesicles identified that promote recovery after ischemic stroke. Otero-Ortega L1, Laso-García F1, Frutos MCG1, Diekhorst L1,

27/02/2020

Influence of oral anticoagulation on stroke severity and outcomes: A propensity score matching case-control study.

27/02/2020

Prehospital selection of thrombectomy candidates beyond large vessel occlusion: M-DIRECT scale

27/02/2020

Mesenchymal Stem Cells From Adipose Tissue Do not Improve Functional Recovery After Ischemic Stroke in Hypertensive Rats.

27/02/2020

Stroke Care and Application of Thrombolysis in Ibero-America: Report From the SITS-SIECV Ibero-American Stroke Register

27/02/2020

The effect of post-stroke hyperglycaemia on the levels of brain damage and repair-related circulating biomarkers: the Glycaemia in Acute Stroke Study

27/02/2020

Regulatory T cells participate in the recovery of ischemic stroke patients

27/02/2020

Intravenous delivery of adipose tissue-derived mesenchymal stem cells improves brain repair in hyperglycemic stroke rats.

27/02/2020

Visual processing speed in hemianopia patients secondary to acquired brain injury: a new assessment methodology.

27/02/2020

Third Ventricle Width Assessed by Transcranial Sonography as Predictor of Long-Term Cognitive Impairment.

27/02/2020

Comment on the article "Symptomatic carotid near-occlusion causes a high risk of recurrent ipsilateral ischemic stroke" by Gu et al.

27/02/2020

Validation of a clinical-genetics score to predict hemorrhagic transformations after rtPA.

27/02/2020

The Chemical Optimization of Cerebral Embolectomy trial: Study protocol.

27/02/2020

Correlation of blood biomarkers with early-onset seizures after an acute stroke event.

27/02/2020

The selective oestrogen receptor modulator, bazedoxifene, mimics the neuroprotective effect of 17β-oestradiol in diabetic ischaemic stroke by mod

26/02/2020

Nighttime hypoxia affects global cognition, memory, and executive function in community-dwelling individuals with hypertension

26/02/2020

Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain.

25/02/2020

In vivo ultrasound-activated delivery of recombinant tissue plasminogen activator from the cavity of sub-micrometric capsules.

25/02/2020

Genome-Wide Association Study of White Blood Cell Counts in Patients With Ischemic Stroke.

25/01/2020

Association of High Serum Levels of Growth Factors with Good Outcome in Ischemic Stroke: a Multicenter Study.

14/01/2020

The selective oestrogen receptor modulator, bazedoxifene, mimics the neuroprotective effect of 17β-oestradiol in diabetic ischaemic stroke by mod

28/11/2019

Cell-Based Therapies for Stroke: Promising Solution or Dead End? Mesenchymal Stem Cells and Comorbidities in Preclinical Stroke Research.

28/11/2019

Cardioembolic Ischemic Stroke Gene Expression Fingerprint in Blood: a Systematic Review and Verification Analysis.

28/11/2019

Lack of the aryl hydrocarbon receptor accelerates aging in mice.

28/11/2019

Targeting PFKFB3 alleviates cerebral ischemia-reperfusion injury in mice.

28/11/2019

Biomarkers predictive value for early diagnosis of Stroke-Associated Pneumonia.

28/11/2019

Usefulness of TNFR1 as biomarker of intracranial aneurysm in patients with spontaneous subarachnoid hemorrhage

28/11/2019

Relevance of Collaterals for the Success of Neuroprotective Therapies in Acute Ischemic Stroke: Insights from the Randomized URICO-ICTUS Trial.

28/11/2019

Clinical Predictors of Hyperperfusion Syndrome Following Carotid Stenting: Results From a National Prospective Multicenter Study.

28/11/2019

Uric Acid Treatment After Stroke Prevents Long-Term Middle Cerebral Artery Remodelling and Attenuates Brain Damage in Spontaneously Hypertensive Rats.

12/12/2018

18th Workshop of the International Stroke Genetics Consortium. Barcelona, 22 y 23 de octubre de 2015

09/10/2015

Blood and CSF biomarkers in brain subcortical ischemic vascular disease: involved pathways and clinical applicability.

22/04/2015

Sequential Abeta degradation by the matrix metalloproteases MMP-2 and MMP-9.

20/04/2015

Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke.

15/04/2015

B-Type Natriuretic Peptides Help in Cardioembolic Stroke Diagnosis: Pooled Data Meta-Analysis.

12/03/2015

BLOOD GLUTAMATE GRABBING DOES NOT REDUCE THE HEMATOMA IN AN INTRACEREBRAL HEMORRHAGE MODEL BUT IT IS A SAFE EXCITOTOXIC TREATMENT MODALITY

02/03/2015

THE ARTICO STUDY: IDENTIFICATION OF PATIENTS AT HIGH RISK OF VASCULAR RECURRENCE AFTER A FIRST NON-CARDIOEMBOLIC STROKE

02/03/2015

Endothelial progenitor cells and revascularization following stroke.

26/02/2015

NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.

17/02/2015

Recommendations from the international stroke genetics consortium, part 1: standardized phenotypic data collection.

20/01/2015

The post-stroke clotting battle: ADAMTS13 falls and puts out of control vWF into brain arteries.

15/01/2015

Stereological and flow cytometry characterization of leukocyte subpopulations in models of transient or permanent cerebral ischemia.

29/12/2014

Neutrophils scan for activated platelets to initiate inflammation.

04/12/2014

Medical and endovascular treatment of patients with large vessel occlusion presenting with mild symptoms: an observational multicenter study.

03/12/2014

Recanalization and Reperfusion Therapies of Acute Ischemic Stroke: What have We Learned, What are the Major Research Questions, and Where are We Heade

27/11/2014

Functional outcome after primary endovascular therapy or IV thrombolysis alone for stroke. An observational, comparative effectiveness study.

21/11/2014

L-kynurenine/aryl hydrocarbon receptor pathway mediates brain damage after experimental stroke.

30/10/2014

REGULATORY T CELLS MODULATE INFLAMMATION AND REDUCE INFARCT VOLUME IN EXPERIMENTAL BRAIN ISCHAEMIA

17/09/2014

Diffusion tensor imaging, intracranial vascular resistance and cognition in middle-aged asymptomatic subjects.

02/09/2014

Toll-like receptor 4 modulates cell migration and cortical neurogenesis after focal cerebral ischemia.

25/07/2014

CLINICAL MANAGEMENT GUIDELINES FOR SUBARACHNOID HAEMORRHAGE. DIAGNOSIS AND TREATMENT.

26/06/2014

Reply to letter "Remarks on cerebral infarct from anotherpoint of view"

17/06/2014

The high-mobility group I-Y transcription factor is involved in cerebral ischemia and modulates the expression of angiogenic proteins.

06/06/2014

GUIDELINES FOR THE PREVENTIVE TREATMENT OF ISCHAEMIC STROKE AND TIA (II). RECOMMENDATIONS ACCORDING TO AETIOLOGICAL SUB-TYPE.

22/04/2014

Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial.

02/04/2014

GUIDELINES FOR THE TREATMENT OF ACUTE ISCHAEMIC STROKE.

25/03/2014

Characterization of Gcf2/Lrrfip1 in experimental cerebral ischemia and its role as a modulator of Akt, mTOR and β-catenin signaling pathways.

14/03/2014

Investigating silent strokes in hypertensives: a magnetic resonance imaging study (ISSYS): rationale and protocol design

20/01/2014

Prognostic Value of Plasma β-Amyloid Levels in Patients With Acute Intracerebral Hemorrhage.

15/01/2014

Diseño web